| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |